Learn more about COVID-19 in Saskatchewan:

Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Advisory Panel to Make MS Research Recommendations

Released on July 16, 2014

The provincial government has named an advisory panel of medical experts, multiple sclerosis (MS) patients and family members and research and health provider groups to recommend options for advancing the science of MS for the benefit of patients.  After reviewing MS-related research opportunities, the panel will submit recommendations to the Ministry of Health in early 2015.

“This advisory panel is an excellent way to engage people with MS and their family members or caregivers in the process of recommending options for MS research and support for patients in Saskatchewan,” Health Minister Dustin Duncan said.  “The personal experience and knowledge of people with strong interests and expertise in this area will inform our consideration of future opportunities for government support.”

The panel includes MS patients and advocates, researchers and medical specialists, as well as representatives from health organizations, the Multiple Sclerosis Society of Canada and the provincial Office of Disability Issues.

The panel will make specific recommendations on opportunities to:
  • enable Saskatchewan patients to participate in clinical trials that focus on improving the condition of patients and relieving symptoms; 
  • improve the care experience of Saskatchewan MS patients; and 
  • better support MS research and education in Saskatchewan.
“We are pleased to be able to work alongside the government and other stakeholders who continue to show a commitment to support MS research and improved patient care in the province,” MS Society of Canada - Saskatchewan Division President Erin Kuan said.  “Research offers people living with MS hope, and we are excited to be part of the discussion about how best to increase research capacity and access to care in Saskatchewan."  

MS is a degenerative neurological disease that impairs or destroys the function of nerve cells in the brain and spinal cord.  About 3,700 Saskatchewan people are affected.

-30-

For more information, contact:

Tyler McMurchy
Health
Regina
Phone: 306-787-4083

We need your feedback to improve saskatchewan.ca. Help us improve